Do analysts recommend SCLX or CABR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scilex 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Caring Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SCLX or CABR more profitable?

Caring Brands has a net margin of 0.00% compared to Scilex's net margin of -1,414.57%. Scilex's return on equity of 0.00% beat Caring Brands' return on equity. Company Net Margins Return on Equity Return on Assets Scilex -1,414.57% N/A -147.00% Caring Brands N/A -1,153.12% -322.63%

Do analysts rate CABR or CLNN?

Clene has a consensus price target of $33.25, indicating a potential upside of 643.85%. Given Clene's stronger consensus rating and higher possible upside, analysts plainly believe Clene is more favorable than Caring Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Caring Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Clene 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71

Is CABR or CLNN more profitable?

Caring Brands has a net margin of 0.00% compared to Clene's net margin of -20,063.96%. Clene's return on equity of 0.00% beat Caring Brands' return on equity. Company Net Margins Return on Equity Return on Assets Caring Brands N/A -1,153.12% -322.63% Clene -20,063.96% N/A -137.04%

Do analysts prefer INCR or CABR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InterCure 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Caring Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is INCR or CABR more profitable?

InterCure's return on equity of 0.00% beat Caring Brands' return on equity. Company Net Margins Return on Equity Return on Assets InterCure N/A N/A N/A Caring Brands N/A -1,153.12% -322.63%

Do analysts rate SCYX or CABR?

SCYNEXIS presently has a consensus price target of $33.00, indicating a potential upside of 497.83%. Given SCYNEXIS's stronger consensus rating and higher possible upside, equities research analysts clearly believe SCYNEXIS is more favorable than Caring Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SCYNEXIS 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Caring Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SCYX or CABR more profitable?

Caring Brands has a net margin of 0.00% compared to SCYNEXIS's net margin of -41.79%. SCYNEXIS's return on equity of -44.15% beat Caring Brands' return on equity. Company Net Margins Return on Equity Return on Assets SCYNEXIS -41.79% -44.15% -32.61% Caring Brands N/A -1,153.12% -322.63%

Do analysts prefer CABR or GRCE?

Grace Therapeutics has a consensus target price of $6.00, suggesting a potential upside of 177.78%. Given Grace Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Grace Therapeutics is more favorable than Caring Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Caring Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Grace Therapeutics 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, CABR or GRCE?

Caring Brands is trading at a lower price-to-earnings ratio than Grace Therapeutics, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Caring Brands N/A N/A -$6.28M -$0.74 N/A Grace Therapeutics N/A N/A -$7.79M -$1.18 N/A

Is CABR or GRCE more profitable?

Grace Therapeutics' return on equity of -36.11% beat Caring Brands' return on equity. Company Net Margins Return on Equity Return on Assets Caring Brands N/A -1,153.12% -322.63% Grace Therapeutics N/A -36.11% -34.39%

Caring Brands (CABR) Competitors

$1.38 +0.05 (+3.76%)

Closing price 08/27/2026 04:00 PM Eastern

Extended Trading

$1.42 +0.04 (+3.19%)

As of 08/27/2026 07:57 PM Eastern

Compare

CABR vs. SCLX, CLNN, INCR, SCYX, and GRCE

Should you buy Caring Brands stock or one of its competitors? Caring Brands's main competitors and comparable companies include Scilex (SCLX), Clene (CLNN), InterCure (INCR), SCYNEXIS (SCYX), and Grace Therapeutics (GRCE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Caring Brands compare to Scilex?

Scilex (NASDAQ:SCLX) and Caring Brands (NASDAQ:CABR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Caring Brands has lower revenue, but higher earnings than Scilex. Caring Brands is trading at a lower price-to-earnings ratio than Scilex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scilex	$31.61M	1.50	-$358.73M	-$49.70	N/A
Caring Brands	N/A	N/A	-$6.28M	-$0.74	N/A

69.7% of Scilex shares are owned by institutional investors. 4.5% of Scilex shares are owned by company insiders. Comparatively, 14.6% of Caring Brands shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Caring Brands has a net margin of 0.00% compared to Scilex's net margin of -1,414.57%. Scilex's return on equity of 0.00% beat Caring Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scilex	-1,414.57%	N/A	-147.00%
Caring Brands	N/A	-1,153.12%	-322.63%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scilex	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Caring Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Scilex and Scilex both had 2 articles in the media. Scilex's average media sentiment score of 0.94 beat Caring Brands' score of 0.45 indicating that Scilex is being referred to more favorably in the media.

Company	Overall Sentiment
Scilex	Positive
Caring Brands	Neutral

Summary

Scilex beats Caring Brands on 6 of the 10 factors compared between the two stocks.

How does Caring Brands compare to Clene?

Caring Brands (NASDAQ:CABR) and Clene (NASDAQ:CLNN) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation.

Clene has a consensus price target of $33.25, indicating a potential upside of 643.85%. Given Clene's stronger consensus rating and higher possible upside, analysts plainly believe Clene is more favorable than Caring Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caring Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Clene	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71

Caring Brands has a net margin of 0.00% compared to Clene's net margin of -20,063.96%. Clene's return on equity of 0.00% beat Caring Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caring Brands	N/A	-1,153.12%	-322.63%
Clene	-20,063.96%	N/A	-137.04%

Caring Brands has higher earnings, but lower revenue than Clene. Caring Brands is trading at a lower price-to-earnings ratio than Clene, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caring Brands	N/A	N/A	-$6.28M	-$0.74	N/A
Clene	$200K	287.20	-$26.17M	-$3.50	N/A

23.3% of Clene shares are owned by institutional investors. 14.6% of Caring Brands shares are owned by company insiders. Comparatively, 28.3% of Clene shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Caring Brands had 1 more articles in the media than Clene. MarketBeat recorded 2 mentions for Caring Brands and 1 mentions for Clene. Clene's average media sentiment score of 0.63 beat Caring Brands' score of 0.45 indicating that Clene is being referred to more favorably in the news media.

Company	Overall Sentiment
Caring Brands	Neutral
Clene	Positive

Summary

Clene beats Caring Brands on 10 of the 14 factors compared between the two stocks.

How does Caring Brands compare to InterCure?

InterCure (NASDAQ:INCR) and Caring Brands (NASDAQ:CABR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InterCure	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Caring Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, InterCure had 4 more articles in the media than Caring Brands. MarketBeat recorded 6 mentions for InterCure and 2 mentions for Caring Brands. InterCure's average media sentiment score of 0.46 beat Caring Brands' score of 0.45 indicating that InterCure is being referred to more favorably in the media.

Company	Overall Sentiment
InterCure	Neutral
Caring Brands	Neutral

Caring Brands has lower revenue, but higher earnings than InterCure. Caring Brands is trading at a lower price-to-earnings ratio than InterCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InterCure	$78.47M	0.79	-$10.37M	$0.03	189.33
Caring Brands	N/A	N/A	-$6.28M	-$0.74	N/A

8.3% of InterCure shares are owned by institutional investors. 0.2% of InterCure shares are owned by insiders. Comparatively, 14.6% of Caring Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

InterCure's return on equity of 0.00% beat Caring Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InterCure	N/A	N/A	N/A
Caring Brands	N/A	-1,153.12%	-322.63%

Summary

InterCure beats Caring Brands on 8 of the 10 factors compared between the two stocks.

How does Caring Brands compare to SCYNEXIS?

SCYNEXIS (NASDAQ:SCYX) and Caring Brands (NASDAQ:CABR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

54.4% of SCYNEXIS shares are held by institutional investors. 4.1% of SCYNEXIS shares are held by insiders. Comparatively, 14.6% of Caring Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Caring Brands has a net margin of 0.00% compared to SCYNEXIS's net margin of -41.79%. SCYNEXIS's return on equity of -44.15% beat Caring Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SCYNEXIS	-41.79%	-44.15%	-32.61%
Caring Brands	N/A	-1,153.12%	-322.63%

SCYNEXIS presently has a consensus price target of $33.00, indicating a potential upside of 497.83%. Given SCYNEXIS's stronger consensus rating and higher possible upside, equities research analysts clearly believe SCYNEXIS is more favorable than Caring Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SCYNEXIS	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Caring Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, SCYNEXIS and SCYNEXIS both had 2 articles in the media. SCYNEXIS's average media sentiment score of 0.93 beat Caring Brands' score of 0.45 indicating that SCYNEXIS is being referred to more favorably in the media.

Company	Overall Sentiment
SCYNEXIS	Positive
Caring Brands	Neutral

Caring Brands has lower revenue, but higher earnings than SCYNEXIS. SCYNEXIS is trading at a lower price-to-earnings ratio than Caring Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SCYNEXIS	$20.60M	2.67	-$8.61M	-$2.09	N/A
Caring Brands	N/A	N/A	-$6.28M	-$0.74	N/A

Summary

SCYNEXIS beats Caring Brands on 8 of the 13 factors compared between the two stocks.

How does Caring Brands compare to Grace Therapeutics?

Caring Brands (NASDAQ:CABR) and Grace Therapeutics (NASDAQ:GRCE) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Grace Therapeutics has a consensus target price of $6.00, suggesting a potential upside of 177.78%. Given Grace Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Grace Therapeutics is more favorable than Caring Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caring Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Grace Therapeutics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Grace Therapeutics' return on equity of -36.11% beat Caring Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caring Brands	N/A	-1,153.12%	-322.63%
Grace Therapeutics	N/A	-36.11%	-34.39%

6.1% of Grace Therapeutics shares are held by institutional investors. 14.6% of Caring Brands shares are held by insiders. Comparatively, 10.8% of Grace Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Caring Brands is trading at a lower price-to-earnings ratio than Grace Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caring Brands	N/A	N/A	-$6.28M	-$0.74	N/A
Grace Therapeutics	N/A	N/A	-$7.79M	-$1.18	N/A

In the previous week, Caring Brands had 1 more articles in the media than Grace Therapeutics. MarketBeat recorded 2 mentions for Caring Brands and 1 mentions for Grace Therapeutics. Grace Therapeutics' average media sentiment score of 1.91 beat Caring Brands' score of 0.45 indicating that Grace Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Caring Brands	Neutral
Grace Therapeutics	Very Positive

Summary

Grace Therapeutics beats Caring Brands on 8 of the 12 factors compared between the two stocks.

Get Caring Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CABR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CABR vs. The Competition

Export

Metric	Caring Brands	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$13.79M	$12.35B	$7.32B	$12.78B
Dividend Yield	N/A	2.61%	2.53%	11.03%
P/E Ratio	-1.86	777.97	271.29	25.71
Price / Sales	N/A	760.53	643.11	107.30
Price / Cash	N/A	95.90	79.17	53.57
Price / Book	-5.31	12.07	13.01	6.26
Net Income	-$6.28M	$2.80B	$3.46B	$348.07M
7 Day Performance	6.98%	1.01%	0.98%	0.47%
1 Month Performance	-8.61%	6.52%	8.59%	5.19%
1 Year Performance	N/A	7.38%	26.54%	16.68%

Caring Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CABR Caring Brands	0.323 of 5 stars	$1.38 +3.8%	N/A	N/A	$13.79M	N/A	N/A	4	Positive News Short Interest Increase
SCLX Scilex	0.9379 of 5 stars	$5.65 -10.9%	N/A	-69.1%	$53.85M	$30.25M	N/A	80	News Coverage Upcoming Earnings
CLNN Clene	2.343 of 5 stars	$4.19 +2.4%	$33.25 +693.6%	-16.9%	$52.55M	$200K	N/A	100	Gap Up
INCR InterCure	0.6919 of 5 stars	$0.93 -2.1%	N/A	-30.3%	$51.95M	$78.47M	31.00	350	News Coverage High Trading Volume
SCYX SCYNEXIS	3.4804 of 5 stars	$5.15 +0.2%	$33.00 +540.8%	-17.4%	$51.14M	$20.60M	N/A	60

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CABR) was last updated on 8/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Caring Brands (CABR) Competitors

CABR vs. SCLX, CLNN, INCR, SCYX, and GRCE

How does Caring Brands compare to Scilex?

Summary

How does Caring Brands compare to Clene?

Summary

How does Caring Brands compare to InterCure?

Summary

How does Caring Brands compare to SCYNEXIS?

Summary

How does Caring Brands compare to Grace Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CABR vs. The Competition

Caring Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Caring Brands (CABR) Competitors

CABR vs. SCLX, CLNN, INCR, SCYX, and GRCE

How does Caring Brands compare to Scilex?

Which has preferable valuation & earnings, SCLX or CABR?

Do institutionals and insiders have more ownership in SCLX or CABR?

Is SCLX or CABR more profitable?

Do analysts recommend SCLX or CABR?

Does the media favor SCLX or CABR?

Summary

How does Caring Brands compare to Clene?

Do analysts rate CABR or CLNN?

Is CABR or CLNN more profitable?

Which has higher valuation and earnings, CABR or CLNN?

Do institutionals & insiders believe in CABR or CLNN?

Does the media refer more to CABR or CLNN?

Summary

How does Caring Brands compare to InterCure?

Do analysts prefer INCR or CABR?

Does the media refer more to INCR or CABR?

Which has stronger valuation and earnings, INCR or CABR?

Do insiders & institutionals believe in INCR or CABR?

Is INCR or CABR more profitable?

Summary

How does Caring Brands compare to SCYNEXIS?

Do insiders and institutionals have more ownership in SCYX or CABR?

Is SCYX or CABR more profitable?

Do analysts rate SCYX or CABR?

Does the media refer more to SCYX or CABR?

Which has higher earnings and valuation, SCYX or CABR?

Summary

How does Caring Brands compare to Grace Therapeutics?

Do analysts prefer CABR or GRCE?

Is CABR or GRCE more profitable?

Do insiders & institutionals believe in CABR or GRCE?

Which has better earnings & valuation, CABR or GRCE?

Does the media prefer CABR or GRCE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CABR vs. The Competition

Caring Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools